Literature DB >> 7742288

Microbial contamination of medications used to treat glaucoma.

O Geyer1, E J Bottone, S M Podos, R A Schumer, P A Asbell.   

Abstract

AIMS: A study was conducted to estimate the frequency of contamination of topical antiglaucoma medications used by asymptomatic patients.
METHODS: The drops and the bottle tips of 194 in use topical medications and the conjunctiva from 109 treated glaucoma patients were cultured.
RESULTS: Bacteria were recovered from 55 (28%) medications. The bottle tip was more frequently contaminated than the drops (p = 0.008). Gram positive organisms were cultured from 50 (91%) of 55 contaminated medications. Thirteen patients (12%) had the same microorganism recovered from the conjunctiva and from the contaminated medication. The frequency of contamination of medications increased with increasing duration of use. Bacterial contamination occurred in 19% of eyedrops less than 8 weeks old in contrast with 40% of bottles used for more than 8 weeks.
CONCLUSION: Our data suggest that ocular medications to treat glaucoma frequently become contaminated with bacteria and that contamination is related to duration of use. We therefore recommend that opened topical antiglaucoma eyedrops should be replaced on a regular basis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742288      PMCID: PMC505106          DOI: 10.1136/bjo.79.4.376

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Bacteriology of normal and infected conjunctiva.

Authors:  R E Perkins; R B Kundsin; M V Pratt; I Abrahamsen; H M Leibowitz
Journal:  J Clin Microbiol       Date:  1975-02       Impact factor: 5.948

2.  The flora of the normal conjunctiva of healthy people in Israel.

Authors:  U BACHRACH; J GUREVITCH; J LANDAU; D BIRNBAUM
Journal:  Acta Med Orient       Date:  1953-01

3.  Microbial contamination of in-use ocular medications.

Authors:  O D Schein; P L Hibberd; T Starck; A S Baker; K R Kenyon
Journal:  Arch Ophthalmol       Date:  1992-01

4.  Bacterial contamination of eyedrop dispensers.

Authors:  C T Coad; M S Osato; K R Wilhelmus
Journal:  Am J Ophthalmol       Date:  1984-11       Impact factor: 5.258

5.  Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles.

Authors:  G Høvding; H Sjursen
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-04

6.  Anaerobic flora of the normal human conjunctival sac.

Authors:  J McNatt; S D Allen; L A Wilson; V R Dowell
Journal:  Arch Ophthalmol       Date:  1978-08

7.  Studies on in-use microbial contamination of eye drops.

Authors:  B Aslund; O T Olson; E Sandell
Journal:  Acta Pharm Suec       Date:  1978

8.  Microbial keratitis associated with contaminated ocular medications.

Authors:  O D Schein; P J Wasson; S A Boruchoff; K R Kenyon
Journal:  Am J Ophthalmol       Date:  1988-04-15       Impact factor: 5.258

9.  Serratia keratitis transmitted by contaminated eyedroppers.

Authors:  W C Templeton; R A Eiferman; J W Snyder; J C Melo; M J Raff
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

10.  Survey of the contamination of eyedrops of hospital inpatients and recommendations for the changing of current practice in eyedrop dispensing.

Authors:  J D Stevens; M M Matheson
Journal:  Br J Ophthalmol       Date:  1992-01       Impact factor: 4.638

  10 in total
  35 in total

1.  Microbial contamination of multi-use ophthalmic solutions in Kenya.

Authors:  M M Nentwich; K H M Kollmann; J Meshack; D R Ilako; U C Schaller
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

2.  Irreversible electroporation for microbial control of drugs in solution.

Authors:  Alex Golberg; Michael Belkin; Boris Rubinsky
Journal:  AAPS PharmSciTech       Date:  2009-07-02       Impact factor: 3.246

3.  To preserve or not to preserve, is that the question?

Authors:  L A Wilson
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

4.  "In use" expiry date for eyedrops.

Authors:  S Rauz; B J Moate; A S Jacks; N Cumberland; J A Govan
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

5.  Trabeculectomy with mitomycin C in the treatment of post-traumatic angle recession glaucoma.

Authors:  T Manners; J F Salmon; A Barron; C Willies; A D Murray
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

6.  Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.

Authors:  Elmer Y Tu
Journal:  Saudi J Ophthalmol       Date:  2014-06-23

7.  Microbial contamination of preservative free eye drops in multiple application containers.

Authors:  M Q Rahman; D Tejwani; J A Wilson; I Butcher; K Ramaesh
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

8.  Bacterial contamination of ophthalmic solutions used in an extended care facility.

Authors:  Danny H-Kauffmann Jokl; Gary P Wormser; Neil S Nichols; Marisa A Montecalvo; Carol L Karmen
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

9.  An evaluation of how glaucoma patients use topical medications: a pilot study.

Authors:  Tony Tsai; Alan L Robin; Judson P Smith
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  How glaucoma patient characteristics, self-efficacy and patient-provider communication are associated with eye drop technique.

Authors:  Robyn Sayner; Delesha M Carpenter; Alan L Robin; Susan J Blalock; Kelly W Muir; Michelle Vitko; Mary Elizabeth Hartnett; Scott D Lawrence; Annette L Giangiacomo; Gail Tudor; Jason A Goldsmith; Betsy Sleath
Journal:  Int J Pharm Pract       Date:  2015-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.